Literature DB >> 24229635

Ocular rosacea: common and commonly missed.

Ana Carolina Vieira1, Mark J Mannis.   

Abstract

Rosacea is a prevalent disorder that may be disfiguring and cause significant ocular morbidity, if not diagnosed and managed appropriately. Ocular rosacea, in particular, is often left undiagnosed as no specific test is available to confirm the diagnosis. Accurate diagnosis is further complicated because symptoms of ocular rosacea are not always specific to the disorder alone. Other ophthalmic disorders may present with similar findings. Further challenges exist because the severity of ocular symptoms is often not related to the severity of cutaneous findings in rosacea. Isolating a disease marker may facilitate earlier diagnosis and treatment, and could also contribute to better understanding of disease pathogenesis. The glycomics of tear fluid and saliva in patients with rosacea shows promise as an initial step in the search for a biomarker specific to the disease. We have previously found potentially important disease biomarkers in roseatic tear and saliva samples. Further investigation should prove important in the early stages of developing a set of markers for accurate disease identification.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  biomarker; conjunctivitis; disease triggers; ocular rosacea; rosacea; saliva; tear break-up time; tear fluid

Mesh:

Year:  2013        PMID: 24229635     DOI: 10.1016/j.jaad.2013.04.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

2.  Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.

Authors:  Aysegul Arman; Duriye Deniz Demirseren; Tamer Takmaz
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Disseminated extrafacial rosacea with papulonecrotic lesions.

Authors:  Toshio Demitsu; Rieko Tsukahara; Naoka Umemoto; Satoshi Nakamura; Kazutaka Nagashima; Tomoko Yamada; Maki Kakurai; Yoshiaki Tanaka; Akihiro Kakehashi; Toshiko Miyata
Journal:  J Dermatol Case Rep       Date:  2016-12-31

Review 4.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

5.  Diagnostic tests in dry eye.

Authors:  Amy Kloosterboer; Harrison Isaac Dermer; Anat Galor
Journal:  Expert Rev Ophthalmol       Date:  2019-08-29

Review 6.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

7.  Prevalence and risk factors for chalazion in an older veteran population.

Authors:  Sneh Patel; Natalia Tohme; Emmanuel Gorrin; Naresh Kumar; Brian Goldhagen; Anat Galor
Journal:  Br J Ophthalmol       Date:  2021-03-31       Impact factor: 5.908

8.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.